TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 120 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $855,367,000 | +38.3% | 11,367 | -50.6% | 0.00% | 0.0% |
Q1 2022 | $618,329,000 | -58.4% | 23,029 | -26.1% | 0.00% | -50.0% |
Q4 2021 | $1,487,191,000 | +98.8% | 31,178 | +176.9% | 0.00% | +100.0% |
Q3 2021 | $748,068,000 | +119.6% | 11,261 | +157.9% | 0.00% | – |
Q2 2021 | $340,713,000 | -27.9% | 4,367 | -12.6% | 0.00% | -100.0% |
Q1 2021 | $472,477,000 | -85.5% | 4,995 | -81.4% | 0.00% | -83.3% |
Q4 2020 | $3,268,992,000 | +363.6% | 26,828 | +232.4% | 0.01% | +500.0% |
Q3 2020 | $705,170,000 | +234.3% | 8,072 | +147.2% | 0.00% | – |
Q2 2020 | $210,951,000 | -66.3% | 3,266 | -76.7% | 0.00% | -100.0% |
Q1 2020 | $625,508,000 | +166.3% | 14,006 | +271.4% | 0.00% | – |
Q4 2019 | $234,896,000 | +558.3% | 3,771 | +297.4% | 0.00% | – |
Q3 2019 | $35,682,000 | +517.4% | 949 | +568.3% | 0.00% | – |
Q2 2019 | $5,779,000 | – | 142 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|